Evidence map›Paper›PMID 25492115›Full record

ArticleJournal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism2015

U0126 attenuates cerebral vasoconstriction and improves long-term neurologic outcome after stroke in female rats.

Hilda Ahnstedt, Maryam Mostajeran, Frank W Blixt, Karin Warfvinge, Saema Ansar, Diana N Krause, Lars Edvinsson

Open access · bronzeAbstract read
In one paragraph

Article in Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 65 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. PMEnvironmental science and pollution research international · 2022
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Dl-3-N-butylphthalide attenuates ischemic reperfusion injury by improving the function of cerebral artery and circulation.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Hilda AhnstedtDivision of Experimental Vascular Research, Department of Clinical Sciences, Lund University, Lund, Sweden.
Maryam MostajeranDivision of Experimental Vascular Research, Department of Clinical Sciences, Lund University, Lund, Sweden.
Frank W BlixtDivision of Experimental Vascular Research, Department of Clinical Sciences, Lund University, Lund, Sweden.
Karin WarfvingeDivision of Experimental Vascular Research, Department of Clinical Sciences, Lund University, Lund, Sweden.
Saema AnsarDivision of Experimental Vascular Research, Department of Clinical Sciences, Lund University, Lund, Sweden.
Diana N KrauseDepartment of Pharmacology, School of Medicine, University of California, Irvine, California, USA.
Lars EdvinssonDivision of Experimental Vascular Research, Department of Clinical Sciences, Lund University, Lund, Sweden.
Lund University · SEUniversity of California, Irvine · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sex differences are well known in cerebral ischemia and may impact the effect of stroke treatments. In male rats, the MEK1/2 inhibitor U0126 reduces ischemia-induced endothelin type B (ETB) receptor upregulation, infarct size and improves acute neurologic function after experimental stroke. However, responses to this treatment in females and long-term effects on outcome are not known. Initial experiments used in vitro organ culture of cerebral arteries, confirming ERK1/2 activation and increased ETB receptor-mediated vasoconstriction in female cerebral arteries. Transient middle cerebral artery occlusion (tMCAO, 120 minutes) was induced in female Wistar rats, with U0126 (30 mg/kg intraperitoneally) or vehicle administered at 0 and 24 hours of reperfusion, or with no treatment. Infarct volumes were determined and neurologic function was assessed by 6-point and 28-point neuroscores. ETB receptor-mediated contraction was studied with myograph and protein expression with immunohistochemistry. In vitro organ culture and tMCAO resulted in vascular ETB receptor upregulation and activation of ERK1/2 that was prevented by U0126. Although no effect on infarct size, U0126 improved the long-term neurologic function after experimental stroke in female rats. In conclusion, early prevention of the ERK1/2 activation and ETB receptor-mediated vasoconstriction in the cerebral vasculature after ischemic stroke in female rats improves the long-term neurologic outcome.

Indexed as

AnimalsButadienesCerebrovascular CirculationDisease Models, AnimalEnzyme InhibitorsFemaleImmunohistochemistryMAP Kinase Signaling SystemNeuroprotective AgentsNitrilesRatsRats, WistarReceptor, Endothelin AReceptor, Endothelin BRecovery of FunctionStrokeButadienesEnzyme InhibitorsNeuroprotective AgentsNitrilesReceptor, Endothelin AReceptor, Endothelin BU 0126

Identifiers

PMID25492115
PMCPMC4348385
OpenAlexW2043666766

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.